Differential role of regulatory T cells in early and late stages of pulmonary fibrosis

Immunobiology

Volumn 218, Issue 2, 2013, Pages 245-254

  Boveda Ruiz, Daniel ^a   D'Alessandro Gabazza, Corina N ^a   Toda, Masaaki ^a   Takagi, Takehiro ^a   Naito, Masahiro ^a   Matsushima, Yuki ^a   Matsumoto, Takahiro ^a   Kobayashi, Tetsu ^a   Gil Bernabe, Paloma ^a   Chelakkot Govindalayathil, Ayshwarya Lakshmi ^a   Miyake, Yasushi ^a   Yasukawa, Atsushi ^a   Morser, John ^b   Taguchi, Osamu ^a   Gabazza, Esteban C ^a  

^a MIE UNIVERSITY   (Japan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bleomycin; Lung fibrosis; Regulatory T cells

Indexed keywords

COLLAGEN; HYDROXYPROLINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; FIBROGENESIS; FIBROTIC SCORE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG WET DRY WEIGHT TO BODY WEIGHT RATIO; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT PARAMETERS; T CELL DEPLETION; TISSUE DISTRIBUTION; WEIGHT CHANGE;

ANIMALS; ANTIBODIES; ANTIGENS, CD4; BLEOMYCIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PULMONARY FIBROSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84871922946     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.020     Document Type: Article

References (33)

1. Ashcroft T., Simpson J.M., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 1988, 41:467-470.
2. Braun R.K., Ferrick C., Neubauer P., Sjoding M., Sterner-Kock A., Kock M., Putney L., Ferrick D.A., Hyde D.M., Love R.B. IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 2008, 31:167-179.
3. D'Alessandro-Gabazza C.N., Kobayashi T., Boveda-Ruiz D., Takagi T., Toda M., Gil-Bernabe P., Miyake Y., Yasukawa A., Matsuda Y., Suzuki N., Saito H., Yano Y., Fukuda A., Hasegawa T., Toyobuku H., Rennard S.I., Wagner P.D., Morser J., Takei Y., Taguchi O., Gabazza E.C. Development and preclinical efficacy of novel transforming growth factor-beta1 short interfering RNAs for pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol. 2012, 46:397-406.
4. Du G., Jin L., Han X., Song Z., Zhang H., Liang W. Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis. Cancer Res. 2009, 69:3205-3212.
5. Fujimoto H., D'Alessandro-Gabazza C.N., Palanki M.S., Erdman P.E., Takagi T., Gabazza E.C., Bruno N.E., Yano Y., Hayashi T., Tamaki S., Sumida Y., Adachi Y., Suzuki K., Taguchi O. Inhibition of nuclear factor-kappaB in T cells suppresses lung fibrosis. Am. J. Respir. Crit. Care Med. 2007, 176:1251-1260.
6. Gilani S.R., Vuga L.J., Lindell K.O., Gibson K.F., Xue J., Kaminski N., Valentine V.G., Lindsay E.K., George M.P., Steele C., Duncan S.R. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010, 5:e8959.
7. Gupte V.V., Ramasamy S.K., Reddy R., Lee J., Weinreb P.H., Violette S.M., Guenther A., Warburton D., Driscoll B., Minoo P., Bellusci S. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 2009, 180:424-436.
8. Harrison J.H., Lazo J.S. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J. Pharmacol. Exp. Ther. 1987, 243:1185-1194.
9. Hoo Z.H., Whyte M.K. Idiopathic pulmonary fibrosis. Thorax 2011, 20:5-15.
10. Hoshino T., Okamoto M., Sakazaki Y., Kato S., Young H.A., Aizawa H. Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. Am. J. Respir. Cell. Mol. Biol. 2009, 41:661-670.
11. Jones A.W. Bleomycin lung damage: the pathology and nature of the lesion. Br. J. Dis. Chest 1978, 72:321-326.
12. Joshi B.H., Hogaboam C., Dover P., Husain S.R., Puri R.K. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases. Vitam. Horm. 2006, 74:479-504.
13. Kikuchi N., Ishii Y., Morishima Y., Yageta Y., Haraguchi N., Itoh K., Yamamoto M., Hizawa N. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir. Res. 2010, 11:31.
14. Kim J.H., Kim H.Y., Kim S., Chung J.H., Park W.S., Chung D.H. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am. J. Pathol. 2005, 167:1231-1241.
15. Kimura T., Ishii Y., Yoh K., Morishima Y., Iizuka T., Kiwamoto T., Matsuno Y., Homma S., Nomura A., Sakamoto T., Takahashi S., Sekizawa K. Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am. J. Pathol. 2006, 169:96-104.
16. King T.E., Pardo A., Selman M. Idiopathic pulmonary fibrosis. Lancet 2011, 378:1949-1961.
17. Kitani A., Fuss I., Nakamura K., Kumaki F., Usui T., Strober W. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 2003, 198:1179-1188.
18. Kotsianidis I., Nakou E., Bouchliou I., Tzouvelekis A., Spanoudakis E., Steiropoulos P., Sotiriou I., Aidinis V., Margaritis D., Tsatalas C., Bouros D. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009, 179:1121-1130.
19. Liu F., Liu J., Weng D., Chen Y., Song L., He Q., Chen J. CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS One 2010, 5:e15404.
20. Lo Re S., Lecocq M., Uwambayinema F., Yakoub Y., Delos M., Demoulin J.B., Lucas S., Sparwasser T., Renauld J.C., Lison D., Huaux F. PDGF-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis. Am. J. Respir. Crit. Care Med. 2011, 184:1270-1281.
21. Luzina I.G., Todd N.W., Iacono A.T., Atamas S.P. Roles of T lymphocytes in pulmonary fibrosis. J. Leukoc. Biol. 2008, 83:237-244.
22. Moore B.B., Hogaboam C.M. Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L152-L160.
23. Nathan S.D., Shlobin O.A., Weir N., Ahmad S., Kaldjob J.M., Battle E., Sheridan M.J., du Bois R.M. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011, 140:221-229.
24. Prud'homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab. Invest. 2007, 87:1077-1091.
25. Rappl G., Pabst S., Riemann D., Schmidt A., Wickenhauser C., Schutte W., Hombach A.A., Seliger B., Grohe C., Abken H. Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation. Clin. Immunol. 2011, 140:71-83.
26. Sharma S.K., MacLean J.A., Pinto C., Kradin R.L. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury. Am. J. Respir. Crit. Care Med. 1996, 154:193-200.
27. Simonian P.L., Wehrmann F., Roark C.L., Born W.K., O'Brien R.L., Fontenot A.P. gammadelta T cells protect against lung fibrosis via IL-22. J. Exp. Med. 2010, 207:2239-2253.
28. -/- mice. Fibrogenesis Tissue Repair. 2010, 3:18.
29. Wilson M.S., Wynn T.A. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009, 2:103-121.
30. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214:199-210.
31. Xu J., Mora A.L., LaVoy J., Brigham K.L., Rojas M. Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L658-L667.
32. Yasui H., Gabazza E.C., Tamaki S., Kobayashi T., Hataji O., Yuda H., Shimizu S., Suzuki K., Adachi Y., Taguchi O. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am. J. Respir. Crit. Care Med. 2001, 163:1660-1668.
33. Yoshimura A., Muto G. TGF-beta function in immune suppression. Curr. Top. Microbiol. Immunol. 2011, 350:127-147.